Oobli Receives FDA No Questions Letter for Oubli Fruit Sweet Protein Made with Precision Fermention
Oobli, formerly Joywell Foods, a sweet protein developer from California, USA, announces that it has received what it claims to be the FDA’s first “No questions” letter for its brazzein protein made with precision fermentation. The US Food and Drug Administration letter confirms Oobli’s self-affirmed GRAS (generally recognized as safe) status for Oubli Fruit Sweet Protein and supports its use as a food and beverage ingredient in the USA. Ali …